Flagship Ventures Fund V, L.P. → Foghorn Therapeutics Inc. FHTX

Stake: 27.20% Shares: 20,774,885 CUSIP: 344174107 Class: Common Stock, $0.0001 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 23/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Passive Schedule 13G filer baseline
High conviction ownership stake (27.2%)
Held by 1 tracked 13F institutional manager
7 NPORT-P mutual funds holding CUSIP
Short interest building (+14.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.17

2,455,127 shares short · +14.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $335K

Point72 Asset Mgmt

Post-Filing Returns · since 2026-01-09 on FHTX

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

+2.8%

Anchor price 6.00 on closest trading day on/after 2026-01-09. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other Filings by Flagship Ventures Fund V, L.P.

Filed	Form	Issuer	Stake	Shares
2023-07-13	SC	Evelo Biosciences, Inc.	—	—	view →
2023-02-27	SC	Omega Therapeutics, Inc.	—	—	view →
2021-02-10	SC	Kaleido Biosciences, Inc.	—	—	view →
2021-02-04	SC	Evelo Biosciences, Inc.	—	—	view →
2020-07-01	SC	Evelo Biosciences, Inc.	—	—	view →
2020-06-08	SC	Kaleido Biosciences, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →